Protecting Pain-Capable Unborn Children from Late-Term Abortions Act
Legislative Progress
Introduced
September 13, 2022
Latest Action
September 13, 2022
Primary Sponsor
Lindsey GrahamRepublican(SC)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Protecting Pain-Capable Unborn Children from Late-Term Abortions Act This bill establishes a new criminal offense for performing or attempting to perform an abortion if the probable gestational age of the fetus is 15 weeks or more. A violator is subject to criminal penalties—a fine, a prison term of up to five years, or both. The bill provides exceptions for an abortion (1) that is necessary to save the life of the pregnant woman, or (2) when the pregnancy is the result of rape or incest. A physician who performs or attempts to perform an abortion under an exception must comply with specified requirements. A woman who undergoes a prohibited abortion may not be prosecuted for violating or conspiring to violate the provisions of this bill.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (10)
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2024 · third_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Client expense: $38,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Client expense: $38,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Client expense: $38,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Client expense: $38,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
2023 · fourth_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of the Pregnant Students Rights Act, which would require institutions of higher education to disseminate information on the rights of, and accommodations and resources for, pregnant students. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria.
2023 · third_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program.
2023 · second_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a letter to the U.S. House issued Jan, 10, 2023. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (H.R. 431) and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program.
2023 · first_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts in support of the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a letter to the U.S. House issued Jan, 10, 2023. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (H.R. 431) and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program.
2022 · fourth_quarter · Family issues/Abortion/Adoption
Endorse S.4840 Protecting Pain-Capable Unborn Children from Late-Term Abortions Act Oppose H.R.8404 Respect for Marriage Act Support inclusion of Senate Amdts. #6482 (Lee), #6496 (Lankford), and #6493 (Rubio) in H.R.8404 Respect for Marriage Act Endorse legislative proposal to prohibit any Federal agency from paying for, or providing reimbursement for, an abortion Oppose inclusion of S. 1927 CAPTA Reauthorization Act, as amended by committee, in H.R.2617 Consolidated Appropriations Act, 2023 Oppose inclusion of S. 1275 Family Violence Prevention and Services Improvement Act, as amended by committee, in H.R.2617 Consolidated Appropriations Act, 2023 Oppose inclusion of H.R. 8296 - Womens Health Protection Act in H.R.2617 Consolidated Appropriations Act, 2023 Oppose inclusion of H.R. 8297 - Ensuring Access to Abortion Act in H.R.2617 Consolidated Appropriations Act, 2023 Oppose inclusion of H.R. 8373 - Right to Contraception Act in H.R.2617 Consolidated Appropriations Act, 2023 Oppose inclusion of H.R. 8404 - Respect for Marriage Act in H.R.2617 Consolidated Appropriations Act, 2023 Endorse H.R.9657 - Protecting Life from Chemical Abortions Act Support changes to S.5276 - Right to Build Families Act to ensure no embryo destruction Oppose H.Res.1434
Client expense: $9,000 · Firm income: Not reported
S. 2175/H.R. 2119, Family Violence Prevention and Services Act, In support of ending domestic violence and in support of programs that provide resources to families experiencing domestic violence; S. Res. 421/H.Res. 746, A resolution supporting the goals and ideals of National Domestic Violence Awareness Month, In support of a resolution supporting programs to end domestic violence; S. 1975/H.R. 3755/S. 4132/H.R. 8296, Women's Health Protection Act of 2021, In support of equal access to safe, legal abortion care; S. 1021/H.R. 2234, EACH Act of 2021, In support of access to abortion services; S. 4354/H.R. 7945, MARCH for Servicemembers Act, In support of reproductive health care and abortion services for military and armed services members; S. 4311/H.R. 5227, LIFT the BAR Act of 2021, In support of removing barriers to Medicaid, CHIP and other public benefit programs for immigrant families; H.R. 8297, Ensuring Access to Abortion Act of 2022, In support of reproductive health care and abortion services for all; S. 4840/H.R. 8814, Protecting Pain-Capable Unborn Children from Late-Term Abortions Act, In opposition to any restrictions prohibiting an individual's access to reproductive health care including abortion services. S. 1927CAPTA Reauthorization of 2021In support of state and community-based child abuse and prevention grants programs, supports for adoption and foster care, and other programs addressing child abuse and neglect. In opposition to restrictions on access to reproductive health care and abortion services
Client expense: $44,000 · Firm income: Not reported
2022 · fourth_quarter · Family issues/Abortion/Adoption
Reproductive Rights and Roe v. Wade; State abortion bans and abortion access in the United States; Administrative actions to protect and expand abortion access; Administrative action to declare a national and public health emergency over Americans access to reproductive care following Dobbs v. Jackson Women Health Organization; Access to abortion care for workers; Access to information and resources for people seeking abortion care and reproductive health services; H.R. 9254, HHS Reproductive and Sexual Health Ombuds Act of 2022, regarding the establishment of an ombuds for reproductive health in the Department of Health and Human Services; H.R. 9247, Abortion Care Awareness Act, regarding an education campaign on abortion access; Access to abortion, contraception, and maternity care for veterans, servicemembers, and dependents; Interim final rule on veterans access to reproductive health services; H.R. 7900, FY23 National Defense Authorization Act; Access to the contraceptive coverage benefit under the Affordable Care Act; Access to contraceptives and reproductive health care without cost-sharing for TRICARE enrollees; Title X family planning program; Teen Pregnancy Prevention Program; Trump administration refusal of care rule; Denials of and nondiscrimination in healthcare; Rescission of the refusal of care rule; Rules implementing Section 1557 of the Affordable Care Act; Treatment of pregnant incarcerated people and detainees; Maternal health outcomes and care options; Paid family and medical leave; LGBTQ+ rights; H.R. 1065 and S. 1486, the Pregnant Workers Fairness Act, regarding discrimination against pregnant workers; H.R. 2234 and S. 1021, the EACH Act of 2021, regarding access to affordable health insurance plans that cover abortion; H.R. 3755, H.R. 8296, S.4132, and S. 1975, the Women's Health Protection Act, regarding access to abortion care; S. 4688, the Reproductive Freedom for All Act, regarding reproductive health decisions; S. 4840 , the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act, regarding restricting access to abortion; Access to evidence-based medication abortion care; H.Res. 1434, regarding access to reproductive health care by reaffirming the Food and Drug Administrations (FDA) authority to preempt state law and ensure access to reproductive health care products; Criminalization of pregnancy outcomes or essential healthcare services; State and local surveillance and investigations of reproductive health activities; Healthcare data privacy; Moderation of abortion mis-and disinformation by social media companies; Free choice of provider in Medicaid programs; Permanent, nationwide extension of postpartum Medicaid coverage.
2022 · fourth_quarter · Family issues/Abortion/Adoption
H.R. 8814, S. 4840 Protecting Pain-Capable Unborn Child from Late-Term Abortions Act; H.R. 8296, S.4132 Womens Health Protection Act; S. 4723 Let Doctors Provide Reproductive Care Act; H.R. 2617 Consolidated Appropriations Act, 2023; H.R. 619, S. 123 Born-Alive Abortion Survivors Protection Act; H.R. 2223 Child Interstate Abortion Notification Act; Veterans Affairs Reproductive Health Services Interim Final Rule; S. 4868, H.R. 8851 Providing for Life Act; H.R. 8926 Protect Pregnancy Care Centers Act; H.R. 705 Heartbeat Protection Act; H.R. 554, S. 78 Support and Value Moms and Babies Act; Defunding abortion providers; Chemical abortion; Congressional Actions against pro-abortion political violence; H.R. 8820 Pharmacist Conscience Protection Act; H.R. 8584, S. 4538 Pregnancy Resource Center Defense Act; H.R. 9657 Protecting Life from Chemical Abortions Act; H.R. 9380 To amend title 10, United States Code, to restrict the Secretary of Defense from paying or reimbursing expenses relating to abortion services; S. 4770, H.R. 9575 No Taxpayer Funds for Illegal Alien Abortions Act; S. 5276 Right to Build Families Act; S. 4543 James M. Inhofe National Defense Authorization Act
Client expense: $300,000 · Firm income: Not reported
2022 · fourth_quarter · Medicare/Medicaid
Issues related to Medicare Advantage and Part D prescription drug programs; Issues related to Prescription Drug Rebates; Issues related to Dual Eligible and Medicare Advantage Special Needs Plans; Issues related to Social Determinants of Health (SDOH)/Health Equity; and Issues related to Telehealth. 117th Congress Inflation Reduction Act of 2022 Budget Reconciliation/Biden Administration Build Back Better Plan COVID-19 American Rescue Plan American Jobs Plan Medicare Sequester COVID Moratorium Act (H.R. 315) Delay of the Prescription Drug Rebate Rule Ensuring Parity in MA for Audio-Only Telehealth Act of 2021 (S. 150) The Ensuring Parity in MA and PACE for Audio-Only Telehealth Act (HR 2166) Previous Congresses H.R. 3461, Community-Based Independence for Seniors Act H.R. 3877, Bipartisan Budget Act H.R. 19, Lower Costs, More Cures Act of 2019 S. 3013, Encouraging Innovative Benefit Design to Lower Costs for Seniors Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 748, CARES Act H.R. 6800, HEROES Act H.R. 7659, Ensuring Parity in MA for Audio-Only Telehealth Act of 2020 S. 4318, American Workers, Families and Employers Assistance Act S. 4199, Prescription Drug Pricing Reduction Act of 2020 S.4840, Ensuring Parity in MA for Audio-Only Telehealth Act of 2020 Bipartisan Coronavirus Relief and Omnibus Funding Bill H.R. 4074, Addressing Social Determinants in Medicare Advantage PL 115-123: H.R. 1892, The bipartisan Budget Act of 2018; H.R. 3168, To amend title XVIII of the Social Security Act to provide continued access to specialized Medicare Advantage plans for special needs individuals, and for other purposes; S. 870, CHRONIC Care Bill PL 115-271: H.R. 6, SUPPORT for Patients and Communities Act
Client expense: $170,000 · Firm income: Not reported
2022 · fourth_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343/H.R. 6702 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support and Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877), and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3755/H.R.8296) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regard to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions including support of a CRA overturning Biden administration regulation (S.J.Res. 41/H.J.Res. 76). Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services. Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2022 (H.R.6536) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to Data Mapping to Save Moms Lives Act (H.R.1218) and impact on abortion reporting. No position taken this quarter. Contacts in support of the Protecting Girls with Turner Syndrome Act of 2022 (H.R.7179) which would prohibit the performance of an abortion on an unborn child due to a diagnosis of Turner syndrome. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to legislation (not introduced) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in regard to the Bipartisan Safer Communities Act (S.2938). No position taken. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (S. 4868/H.R. 8851 Providing for Life Act, H.R. 8384/S.4541 Standing with Moms Act, and others). Contacts in regards legislation to respond to violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case. Contacts in opposition to the Build Back Better reconciliation bill (H.R. 5376). H.R. 5376 contains numerous provisions to fund elective abortion in violation of the longstanding principles of the Hyde Amendment, would mandate abortion funding in Affordable Care Act (Obamacare) plans in states that did not expand Medicaid in 2024, and direct billions of dollars to various public health grants without Hyde Amendment protections. Contacts in opposition to the Right to Contraception Act (H.R. 8373) which includes provisions related to the funding of abortion providers and includes language that could permit the use of drugs to induce an abortion weeks or months into a pregnancy. Contacts in opposition to H. Res. 1434 dealing with the preemption of state law in regard to abortion drugs. Contacts regarding H. R. 6878, the Pregnant Women in Custody Act, as it relates to travel for abortion. No position taken.
2022 · third_quarter · Family issues/Abortion/Adoption
H.R. 8814, S. 4840 Protecting Pain-Capable Unborn Child from Late-Term Abortions Act; H.R. 8297 Ensuring Womens Right to Reproductive Freedom Act; H.R. 8296, S.4132 Womens Health Protection Act; S. 4723 Let Doctors Provide Reproductive Care Act; H.R. 8373 Right to Contraception Act; H.R. 8294 FY 2023 Consolidated Appropriations Act (T-HUD, Ag, Energy-Water, FSGG, Interior, MilCon/VA); H.R. 619, S. 123 Born-Alive Abortion Survivors Protection Act; H.R. 2223 Child Interstate Abortion Notification Act; H.R. 5376 Inflation Reduction Act; S. 1198 Solid Start Act of 2022; Veterans Affairs Reproductive Health Services Interim Final Rule; S. 4868, H.R. 8851 Providing for Life Act; H.R. 8926 Protect Pregnancy Care Centers Act; H.R. 6833 FY2023 Continuing Appropriations and Ukraine Supplemental Appropriations Act; H.R. 705 Heartbeat Protection Act; H.R. 554, S. 78 Support and Value Moms and Babies Act; Defunding abortion providers; Maternal Mortality; Chemical abortion; Bioethics; Congressional Actions against pro-abortion political violence; H.R. 8820 Pharmacist Conscience Protection Act; H.R. 8702 Taxpayers Support Life Act; H.R. 8584, S. 4538 Pregnancy Resource Center Defense Act
Client expense: $310,000 · Firm income: Not reported
2022 · third_quarter · Family issues/Abortion/Adoption
Support for reproductive rights in the following legislation and government actions: H.R. 3755/S. 1975, Womens Health Protection Act of 2021 and H.R. 8296/S. 4132, Womens Health Protection Act of 2022 Dobbs v. Jackson Womens Health Organization and potential legislative responses H.R. 8297, Ensuring Womens Right to Reproductive Freedom Act of 2022 and S. 4504, Freedom to Travel for Health Care Act of 2022 H.R. 8650/S. 4723, Let Doctors Provide Reproductive Health Care Act H.R. 8373/S. 4557/S. 4612, Right to Contraception Act H.R. 8404/S. 4556, Respect for Marriage Act H.R. 9040/S. 4764, Reproductive Health Care Accessibility Act Judicial nominations H.R. 2709/S. 1238, Access to Contraception for Servicemembers and their Dependents Act of 2021 S. 4700, Equal Access to Contraception for Veterans Act H.R. 2819, Solid Start Act of 2021 H.R. 2234, EACH Act of 2021 Urging emergency funding for the Title X Family Planning Program and other potential legislation to increase access to contraception and family planning services S. 4641, Abortion is Healthcare Everywhere Act of 2022 H.R. 5376, Build Back Better Act (and issues around maternal health) H.R. 3149/S. 1660, HEAL for Immigrant Families Act of 2021 Potential legislation addressing access to assisted reproduction and fertility care Feedback on legal provisions in: H.R. 8867, SAFE For Patients Act S. 4748, Protecting National Access to Reproductive Care Act of 2022 H.R. 8424/S. 4550, Expanding Access to Family Planning Act Expressing deep concerns with all the provisions in: S. 4688, Reproductive Freedom for All Act H.R. 8421, Access to Safe Contraception Act of 2022 Opposing all the provisions in: H.R. 8814/S. 4840, Protecting Pain-Capable Unborn Children from Late-Term Abortions Act
Client expense: $50,000 · Firm income: Not reported
S. 2175/H.R. 2119, Family Violence Prevention and Services Act, In support of ending domestic violence and in support of programs that provide resources to families experiencing domestic violence; S. Res. 421/H.Res. 746, A resolution supporting the goals and ideals of National Domestic Violence Awareness Month, In support of a resolution supporting programs to end domestic violence; S. 1975/H.R. 3755/S. 4132/H.R. 8296, Women's Health Protection Act of 2021, In support of equal access to safe, legal abortion care; S. 1021/H.R. 2234, EACH Act of 2021, In support of access to abortion services; S. 4354/H.R. 7945, MARCH for Servicemembers Act, In support of reproductive health care and abortion services for military and armed services members; S. 4311/H.R. 5227, LIFT the BAR Act of 2021, In support of removing barriers to Medicaid, CHIP and other public benefit programs for immigrant families; H.R. 8297, Ensuring Access to Abortion Act of 2022, In support of reproductive health care and abortion services for all; S. 4840/H.R. 8814, Protecting Pain-Capable Unborn Children from Late-Term Abortions Act, In opposition to any restrictions prohibiting an individual's access to reproductive health care including abortion services.
Client expense: $87,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Family issues/Abortion/Adoption
Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814) Women's Health Protection Act (S. 4132) Women's Health Protection Act (H.R. 3755) Let Doctors Provide Reproductive Health Care Act (S. 4723/H.R. 8650) The Equal Access to Abortion Coverage (EACH) Act (H.R. 2234/S. 1021) Freedom to Travel for Health Care Act (S. 4504)
Client expense: $10,243 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Family issues/Abortion/Adoption
Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814) Women's Health Protection Act (S. 4132) Women's Health Protection Act (H.R. 3755) PRO-LIFE Act of 2022 (H.R. 8862) EQUIP Act of 2022 (H.R. 8834) The Equal Access to Abortion Coverage (EACH) Act (H.R. 2234/S. 1021) Saving Abortion Facilities from Extremists (SAFE) for Patients Act (H.R. 8867) The Financial Data and Reproductive Justice Act Abortion Care Awareness Act of 2022 (not yet introduced) HHS Reproductive and Sexual Health Ombuds Act of 2022 Reproductive Health Care Accessibility Act (S. 4764/H.R. 9040) Freedom to Travel for Health Care Act (S. 4504) Ensuring Access to Abortion Act (H.R. 8297) Protecting National Access to Reproductive Care Act (S. 4748) Womens Health Patient Navigators Act (not yet introduced) Misinformation Public Awareness Campaign (not yet introduced) Reproductive Health Travel Fund Act (H.R. 8452) Preserving Access to Essential Medications Act (not yet introduced) Expressing opposition to the criminalization of essential health care, including the full range of sexual and reproductive health care such as abortion, gender-affirming care, and contraceptive care, and disapproving of the criminalization of pregnancy outcomes (H.Con.Res.89/S.Res. 644)
Client expense: $82,882 · Firm income: Not reported
2022 · third_quarter · Family issues/Abortion/Adoption
S. 4770; No Taxpayer Funds for Illegal Alien Abortions Act, Prohibiting DHS from using federal funding for abortion H.R. 8820; Pharmacist Conscience Protection Act, Protecting the conscience rights of pharmacists regarding the administration of abortion-inducing drugs H.R. 5376; Inflation Reduction Act of 2022, Prohibiting abortion funding and protecting faith-based organizations from politicized IRS audits H.R. 1011; Life at Conception Act, Protecting unborn life from the moment of conception H.R. 8297; Ensuring Women's Right to Reproductive Freedom Act, Ensuring the states' ability to enforce laws protecting unborn life H.R. 705; Heartbeat Protection Act of 2021, Protecting unborn life from the moment a heartbeat can be detected H.R. 8835; A bill to prohibit the use of Federal funds to implement Executive Order relating to reproductive health services, Prohibiting the federal government from implementing executive order promoting abortion H.R. 8364; Protecting Kids, Protecting Lunches Act of 2022, Prohibiting the politisation of school lunch programs H.R. 8814 / S. 4840; Protecting Pain-Capable Unborn Children from Late-Term Abortions Act, Protecting unborn life at 15 weeks gestation S. 4868; Providing for Life Act, Improving existing federal programs to better support pregnant women and their children H.R. 8404; Respect for Marriage Act, Ensuring religious liberty and protections for children H.R. 8373; Right to Contraception Act, Prohibiting the expansion of chemical abortion drugs Stop the Sexualization of Children, Ensuring protections for children and parental rights H.R. 8702; Taxpayers Support Life Act, Prohibiting funding to implement the HHS proposed rule on Section 1557 of the ACA H.R. 8294; Transportation, Housing and Urban Development, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, and Veterans Affairs Appropriations Act, 2023, Prohibiting the funding and promotion of abortion H.R. 8296 / S. 4132; Womens Health Protection Act of 2022, Stopping further legalization of abortion and elimination of state pro-life laws H.R. 7780; Mental Health Matters Act, Ensuring protections for children and parental rights
2022 · third_quarter · Family issues/Abortion/Adoption
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343/H.R. 6702 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877), and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3755/H.R.8296) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Care for Her Act (H.R. 5163) to extend services for pregnant women. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regards to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions including support of a CRA overturning Biden administration regulation (S.J.Res. 41/H.J.Res. 76). Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services. Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2022 (H.R.6536) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regards to Data Mapping to Save Moms Lives Act (H.R.1218) and impact on abortion reporting. No position taken this quarter. Contacts in support of the Protecting Girls with Turner Syndrome Act of 2022 (H.R.7179) which would prohibit the performance of an abortion on an unborn child due to a diagnosis of Turner syndrome. Contacts in regards to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to legislation (not introduced) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs. Contacts in regards to the Bipartisan Safer Communities Act (S.2938). No position taken. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (S. 4868/H.R. 8851 Providing for Life Act, H.R. 8384/S.4541 Standing with Moms Act, and others). Contacts in regards to violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case. Contacts in regards to the Central American Women and Children Protection Act of 2021 (H.R.4017). No position taken.
2022 · third_quarter · Family issues/Abortion/Adoption
Reproductive Rights and Roe v. Wade; State abortion bans and abortion access in the United States; Administrative actions to protect and expand abortion access; Administrative action to declare a national and public health emergency over Americans access to reproductive care following Dobbs v. Jackson Women Health Organization; Access to abortion care for workers; Access to information and resources for people seeking abortion care and reproductive health services; Access to abortion, contraception, and maternity care for veterans, servicemembers, and dependents; H.R. 8916, the Access to Reproductive Care for Servicemembers Act, regarding leave policies for servicemembers to seek abortion care; Interim final rule on veterans access to reproductive health services; H.R. 7900, FY23 National Defense Authorization Act; Access to the contraceptive coverage benefit under the Affordable Care Act; Access to contraceptives and reproductive health care without cost-sharing for TRICARE enrollees; Title X family planning program; H.R. 8424 and S. 4550, Expanding Access to Family Planning Act, Access to over-the-counter contraception; Trump administration refusal of care rule; Denials of and nondiscrimination in healthcare; Rescission of the refusal of care rule; Rules implementing Section 1557 of the Affordable Care Act; Treatment of pregnant incarcerated people and detainees; Maternal health outcomes and care options; Paid family and medical leave; LGBTQ+ rights; H.Res. 1209, recognizing that it is the duty of the Federal Government to develop and implement a Transgender Bill of Rights; H.R. 804 and S. 248, FAMILY Act, regarding paid family leave; H.R. 1065 and S. 1486, the Pregnant Workers Fairness Act, regarding discrimination against pregnant workers; H.R. 5 and S. 393, the Equality Act, regarding ending discrimination for LGBTQIA+ individuals; H.R. 2234 and S. 1021, the EACH Act of 2021, regarding access to affordable health insurance plans that cover abortion; H.R. 3755, H.R. 8296, S.4132, and S. 1975, the Women's Health Protection Act, regarding access to abortion care; S. 3713, the Reproductive Choice Act, regarding limited access to abortion care; H.R. 8297, the Ensuring Womens Right to Reproductive Freedom Act, regarding the right to travel to access reproductive healthcare; H.R. 8452, the Reproductive Health Travel Fund Act of 2022, regarding financial support for people traveling to access abortion care; H.R. 8373 and S.4557, the Right to Contraception Act, regarding the an individuals right to use and provide contraceptives and related counseling; H.R. 8650 and S. 4723, the Let Doctors Provide Reproductive Health Care Act, regarding protections for healthcare providers; H.Con.Res. 109, Concurrent Resolution, regarding support for the recognition of September 26, 2022, as World Contraception Day and expressing the sense of the House of Representatives regarding global and domestic access to contraception; H.R. 9040 and S.4764, the Reproductive Health Care Accessibility Act, regarding expanding access to reproductive health care for people with disabilities; S. 4688, the Reproductive Freedom for All Act, regarding reproductive health decisions; S. 4840, the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act, regarding restricting access to abortion; Access to evidence-based medication abortion care; H.Res. 1434, regarding access to reproductive health care by reaffirming the Food and Drug Administrations (FDA) authority to preempt state law and ensure access to reproductive health care products; Criminalization of pregnancy outcomes or essential healthcare services; H.Con.Res. 89, Concurrent Resolution, regarding the criminalization of essential health care, including the full range of sexual and reproductive health care such as abortion; Healthcare data privacy; H.R. 8111, My Body, My Data Act of 2022, regarding data privacy; Moderation of abortion mis-and disinformation by social media companies; Free choice of provider in Medicaid programs; Violence against women; S. 3623 and H.R. 1620, Violence Against Women Reauthorization Act of 2022.
2022 · third_quarter · Family issues/Abortion/Adoption
Lobbied in support of H.R.705 Heartbeat Protection Act of 2021 and advise on post-Dobbs messaging Recommended questions for the record for oversight of regulation on chemical abortion. Endorsed and lobbied in support of H.R.8384/S.4541 Standing With Moms Act. Endorse S.4539 Month of Life Celebration Act. Reviewed and provided feedback on potential legislation to expand the adoption tax credit. Lobbied against H.R.8296 - Womens Health Protection Act of 2022. Lobbied against H.R.8297 - Ensuring Access to Abortion Act of 2022. Endorsed H.R.8501 - Preventing Abortion Sanctuaries Act. Reviewed potential legislation to define and support pregnancy centers. Lobbied against H.R.8373/S.4556 Respect for Marriage Act. Endorsed S.Res.729 A resolution designating the week beginning November 7, 2022, as "National Pregnancy Center Week" to recognize the vital role that community-supported pregnancy centers play in saving lives and serving women and men faced with difficult pregnancy decisions. Recommended roundtable of pro-life women legislators to set policy priorities for federal life protections. Lobbied for S.1156 Adoption Tax Credit Refundability Act of 2021. Joined letters to the U.S. Department of Justice urging investigation of attacks on pro-life charities. Endorsed H.R.8776 No Federal Funds for Abortion Travel Expenses Act of 2022. Endorsed H.R.8851/S.4868 Providing for Life Act. Lobbied for H.R.8814/S.4840 Protecting Pain-Capable Unborn Children from Late-Term Abortions Act. Endorsed Commitment to America by Republican Leader Kevin McCarthy. Endorsed Family Policy Agenda by Republican Study Committee. Endorsed oversight letter to crowdsource-recommendation website regarding its policies targeting pregnancy resource centers. Endorsed H.R.7816 - Respectful Treatment of Unborn Remains Act of 2022.
2022 · third_quarter · Medicare/Medicaid
Issues related to Medicare Advantage and Part D prescription drug programs; Issues related to Prescription Drug Rebates; Issues related to Dual Eligible and Medicare Advantage Special Needs Plans; Issues related to Social Determinants of Health (SDOH)/Health Equity; and Issues related to Telehealth. 117th Congress Inflation Reduction Act of 2022 Budget Reconciliation/Biden Administration Build Back Better Plan COVID-19 American Rescue Plan American Jobs Plan Medicare Sequester COVID Moratorium Act (H.R. 315) Delay of the Prescription Drug Rebate Rule Ensuring Parity in MA for Audio-Only Telehealth Act of 2021 (S. 150) The Ensuring Parity in MA and PACE for Audio-Only Telehealth Act (HR 2166) Previous Congresses H.R. 3461, Community-Based Independence for Seniors Act H.R. 3877, Bipartisan Budget Act H.R. 19, Lower Costs, More Cures Act of 2019 S. 3013, Encouraging Innovative Benefit Design to Lower Costs for Seniors Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 748, CARES Act H.R. 6800, HEROES Act H.R. 7659, Ensuring Parity in MA for Audio-Only Telehealth Act of 2020 S. 4318, American Workers, Families and Employers Assistance Act S. 4199, Prescription Drug Pricing Reduction Act of 2020 S.4840, Ensuring Parity in MA for Audio-Only Telehealth Act of 2020 Bipartisan Coronavirus Relief and Omnibus Funding Bill H.R. 4074, Addressing Social Determinants in Medicare Advantage PL 115-123: H.R. 1892, The bipartisan Budget Act of 2018; H.R. 3168, To amend title XVIII of the Social Security Act to provide continued access to specialized Medicare Advantage plans for special needs individuals, and for other purposes; S. 870, CHRONIC Care Bill PL 115-271: H.R. 6, SUPPORT for Patients and Communities Act
Client expense: $147,000 · Firm income: Not reported
2022 · second_quarter · Medicare/Medicaid
Issues related to Medicare Advantage and Part D prescription drug programs; Issues related to Prescription Drug Rebates; Issues related to Dual Eligible and Medicare Advantage Special Needs Plans; Issues related to Social Determinants of Health (SDOH)/Health Equity; and Issues related to Telehealth. 117th Congress Budget Reconciliation/Biden Administration Build Back Better Plan COVID-19 American Rescue Plan American Jobs Plan Medicare Sequester COVID Moratorium Act (H.R. 315) Delay of the Prescription Drug Rebate Rule Ensuring Parity in MA for Audio-Only Telehealth Act of 2021 (S. 150) The Ensuring Parity in MA and PACE for Audio-Only Telehealth Act (HR 2166) Previous Congresses H.R. 3461, Community-Based Independence for Seniors Act H.R. 3877, Bipartisan Budget Act H.R. 19, Lower Costs, More Cures Act of 2019 S. 3013, Encouraging Innovative Benefit Design to Lower Costs for Seniors Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 748, CARES Act H.R. 6800, HEROES Act H.R. 7659, Ensuring Parity in MA for Audio-Only Telehealth Act of 2020 S. 4318, American Workers, Families and Employers Assistance Act S. 4199, Prescription Drug Pricing Reduction Act of 2020 S.4840, Ensuring Parity in MA for Audio-Only Telehealth Act of 2020 Bipartisan Coronavirus Relief and Omnibus Funding Bill H.R. 4074, Addressing Social Determinants in Medicare Advantage PL 115-123: H.R. 1892, The bipartisan Budget Act of 2018; H.R. 3168, To amend title XVIII of the Social Security Act to provide continued access to specialized Medicare Advantage plans for special needs individuals, and for other purposes; S. 870, CHRONIC Care Bill PL 115-271: H.R. 6, SUPPORT for Patients and Communities Act
Client expense: $184,000 · Firm income: Not reported
2022 · first_quarter · Medicare/Medicaid
Issues related to Medicare Advantage and Part D prescription drug programs; Issues related to Prescription Drug Rebates; Issues related to Dual Eligible and Medicare Advantage Special Needs Plans; Issues related to Social Determinants of Health (SDOH)/Health Equity; and Issues related to Telehealth. 117th Congress Budget Reconciliation/Biden Administration Build Back Better Plan COVID-19 American Rescue Plan American Jobs Plan Medicare Sequester COVID Moratorium Act (H.R. 315) Delay of the Prescription Drug Rebate Rule Ensuring Parity in MA for Audio-Only Telehealth Act of 2021 (S. 150) The Ensuring Parity in MA and PACE for Audio-Only Telehealth Act (HR 2166) Previous Congresses H.R. 3461, Community-Based Independence for Seniors Act H.R. 3877, Bipartisan Budget Act H.R. 19, Lower Costs, More Cures Act of 2019 S. 3013, Encouraging Innovative Benefit Design to Lower Costs for Seniors Act H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 748, CARES Act H.R. 6800, HEROES Act H.R. 7659, Ensuring Parity in MA for Audio-Only Telehealth Act of 2020 S. 4318, American Workers, Families and Employers Assistance Act S. 4199, Prescription Drug Pricing Reduction Act of 2020 S.4840, Ensuring Parity in MA for Audio-Only Telehealth Act of 2020 Bipartisan Coronavirus Relief and Omnibus Funding Bill H.R. 4074, Addressing Social Determinants in Medicare Advantage PL 115-123: H.R. 1892, The bipartisan Budget Act of 2018; H.R. 3168, To amend title XVIII of the Social Security Act to provide continued access to specialized Medicare Advantage plans for special needs individuals, and for other purposes; S. 870, CHRONIC Care Bill PL 115-271: H.R. 6, SUPPORT for Patients and Communities Act
Client expense: $300,000 · Firm income: Not reported
| Republican |
| SD |
| Josh Hawley | Republican | MO |
| Kevin Cramer | Republican | ND |
| Marco Rubio | Republican | FL |
| Roger Marshall | Republican | KS |
| Steve Daines | Republican | MT |
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $10,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $20,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE